Impact of small variations of ischemia time after polyclonal antithymocyte globulins in a nonhuman primate model of ischemia-reperfusion injury.
Ischemia-reperfusion injury leads to increased leukocyte adherence enhancing acute cellular rejection, causing microvascular dysfunction and tissue damage. The length of the ischemic time is important in clinical transplantation. Polyclonal antithymocyte globulins (pATGs) induce T-cell depletion and functional impairment of nondepleted lymphocytes. In this study cynomolgus monkeys were used to evaluate the impact of three different pATGs on the microcirculation, on leukocyte behavior and infiltration, as well as on tissue damage after two different periods of ischemia (60 and 150 minutes). pATGs were administered 30 minutes before ex vivo reperfusion. Using intravital fluorescence microscopy, the postreperfusion microcirculation was visualized in vivo. Morphologic analyses were performed on biopsies obtained after the experiments. Significant differences were observed between the two periods of ischemia in both the ATG-treated and control groups. Minimizing ischemia time, even in short intervals, improves the outcome of ischemia-reperfusion injury by reducing leukocyte adherence to the antigen-presenting endothelial cells, improving the microcirculation, and reducing tissue damage.
Beiras-Fernandez
A
A
Institute for Surgical Research, University of Munich, 81377 Munich, Germany.
Chappel
D
D
Thein
E
E
Hammer
C
C
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001706:Biopsy; D001783:Blood Flow Velocity / Q000187:drug effects; D004195:Disease Models, Animal; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007511:Ischemia / Q000503:physiopathology*; D008252:Macaca fascicularis; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000473:pathology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents